Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection

Journal of Neuroimmunology

Volumn 74, Issue 1-2, 1997, Pages 185-197

  Morris, Margaret M ^a   Dyson, Heather ^b   Baker, David ^c   Harbige, Laurence S ^a   Fazakerley, John K ^b   Amor, Sandra ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cytokines; demyelination; immunocytochemistry; Semliki Forest virus

Indexed keywords

CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; FEMALE; IMMUNOHISTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

EID: 0030890792     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00786-2     Document Type: Article

References (74)

1. Allen, S.J., Baker, D., O'Neill, J.K., Davison, A.N. and Turk, J.L. (1993) Isolation and characterisation of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell. Immunol. 146, 335-350.
2. Amor, S. and Webb, H.E. (1987) The effects of cycloleucine on SFV A7(74) infection in mice. Br. J. Exp. Path. 68, 225-235.
3. Amor, S. and Webb, H.E. (1988) CNS pathogenesis following a dual viral infection with Semliki Forest (Alphavirus) and Langat (Flavivirus). Br. J. Exp. Path. 69, 197-208.
4. Amor, S., Scallan, M.F., Morris, M.M., Dyson, H. and Fazakerley, J.K. (1996) Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis. J. Gen. Virol. 77, 281-291.
5. Ando, D.G., Clayton, J., Kono, D., Urban, J.L. and Sercarz, E.E. (1989) Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th1 lymphokine subtype. Cell. Immunol. 24, 132-143.
6. Baker, D., O'Neill, J.K., Gschmeissner, S.E., Wilcox, C., Butter, C. and Turk, J.L. (1990) Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J. Neuroimmunol. 28, 261-270.
7. Baker, D. O'Neill, J.K. and Turk, J.L. (1991) Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell. Immunol. 134, 505-510.
8. Baker, D., Butler, D., Scallon, B.J., O'Neill, J.K., Turk, J.L. and Feldmann, M. (1994) Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24, 2040-2048.
9. Barten, D.M. and Ruddle, N.H. (1994) Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51, 123-133.
10. Bradish, C.J., Allner, K. and Fitzgeorge, R. (1975) Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide. J. Gen. Virol. 28, 225-237.
11. Butter, C., O'Neill, J.K., Baker, D., Gschmeissner, S.E. and Turk, J.K. (1991) An immunoelectron microscopical study of the expression of class II major histocompatability complex during experimental allergic encephlaomyelitis in Biozzi AB/H mice. J. Neuroimmunol. 33, 37-42.
12. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D., Oldstone, M.B.A. and Mucke, L. (1993) Neurological disease induced in transgenic mice by cerebral overexpression of interleukin-6. Pro. Natl. Acad. Sci. (USA) 90, 10061-10065.
13. Cammer, W., Bloom, B.R., Norton, W.T. and Gordon, S. (1978) Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. USA. 75, 1554-1558.
14. Cannella, B., Gao, Y.-L., Brosnan, C.F. and Raine, C.S. (1994) IL-10 enhances experimental allergic encephalomyelitis. J. Neuroimmunol. 54, 155.
15. Cannella, B. and Raine, C.S. (1995). The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435.
16. Cohen, S.B., Katsikis, P.D., Feldmann, M. and Londei, M. (1994) IL-10 enhances expression of the IL-2 receptor alpha chain on T cells. Immunol. 83, 329-332.
17. Duong, T.T., St-Louis, J., Gilbert, J.J., Finkelman, F.D. and Strejan, G.H. (1992) Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mice. J. Neuroimmunol. 36, 105-115.
18. Espevik, T., Figari, I.S., Shalaby, M.R., Lackides, G.A., Lewis. G.D., Shephard, H.M. and Palladino, M.A. (1987) Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166, 571-576.
19. Farrar, W.L., Vinocour, M. and Hill, J.M. (1989) In situ hybridization histochemistry localization of interleukin-3 mRNA in mouse brain. Blood 73, 137-140.
20. Fazakerley, J.K., Amor, S. and Webb, H.E. (1983) Reconstitution of Semliki Forest virus infected mice induces immune mediated pathological changes in the CNS. Clin. Exp. Immunol. 52, 115-120.
21. Fazakerley, J.K. and Webb, H.E. (1987a) Semliki Forest virus induced, immune mediated demyelination: the effects of irradiation. Br. J. Exp. Pathol. 68, 101-113.
22. Fazakerley, J.K. and Webb, H.E. (1987b) Semliki Forest virus induced, immune mediated demyelination: Adoptive transfer studies and viral persistence in nude mice. J. Gen. Virol. 68, 377-385.
23. Fazakerley, J.K., Pathak, S., Scallan, M., Amor, S. and Dyson, H. (1993) Replication of the A7(74) strain of Semliki Forest virus is restricted to neurons. Virology 195, 627-637.
24. Fontana, A., Frei, K., Bodmer, S., Hofer, E., Schreier, M.H., Palladino, M.A. and Zinkernagel, R.M. (1989) Transforming growth factor-β inhibits the generation of cytotoxic T cells in virus-infected mice. J. Immunol. 143, 3230-3234.
25. Frei, K., Malipiero, U.V., Leist, T.P., Zinkernagel, R.M., Schwab, M.E. and Fontana, A. (1989) On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19, 689-694.
26. Gijbels, K., Van Damme, J., Proost, P., Put, W., Carton, H. and Billiau, A. (1990) Interleukin 6 production in the central nervous system during experimental allergic encephalomyelitis. Eur. J. Immunol. 20, 233-235.
27. Guy, J., Ellis, E.A., Hope, G.M. and Rao, N.A. (1989) Antioxidant enzyme suppression of demyelination in experimental optic neuritis. Curr. Eye Res. 8, 467-477.
28. Gogate, N., Bakhiet, M., Kristensson, K., Norrby, E. and Olsson T. (1991) Gamma interferon expression and major histocompatability complex induction during measles and vesicular stomatitis virus infections of the brain. J. Neuroimmunol. 31, 19-26.
29. Huitinga, I., Ruuls, S.R., Jung, S., Van Rooijen, N., Hartung, H.P. and Dijkstra, C.D. (1995) Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin. Exp. Immunol. 100, 344-351.
30. Jagelman, S., Suckling, A.J., Webb, H.E. and Bowen, E.T.W. (1978) The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice. J. Gen. Virol. 41, 599-607.
31. Jenkins, H.G. and Ikeda, H. (1992) Tumour necrosis factor causes an increase in axonal transport of protein and demyelination in the mouse optic nerve. J. Neurol. Sci. 108(1), 99-104.
32. Joseph, J., Grun, J.L., Lublin, F.D. and Knobler R.L. (1993) Interleukin-6 induction in vitro in mouse brain endothelial cells and astrocytes by exposure to mouse hepatitis virus (MHV-4, JHM). J. Neuroimmunol. 42, 47-52.
33. Kelly, W.R., Blakemore, W.F., Jagelman, S. and Webb, H.E. (1982) Demyelination induced in mice by avirulent Semliki Forest virus, Part 2 (An ultrastructural study of focal demyelination in the brain). Neuropathol. Appl. Neurobiol. 2, 43-53.
34. Kennedy, M.K., Torrance, D.S., Picha, K.S. and Mohler, K.M. (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with EAE reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149, 2496-2505.
35. Khoury, S.J., Hancock, W.W. and Weiner, H.L. (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364.
36. Kundig, T.M., Hengartner, H. and Zinkernagel, R.M. (1993) T cell-dependent IFN-gamma exerts an anti-viral effect in the central nervous system but not in peripheral solid organs. J. Immunol. 150, 2316-2321.
37. Kuroda, Y. and Shimamoto, Y. (1991) Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 34, 159-164.
38. Lampson, L.A. (1987) Molecular basis of immune response to neural antigens. Trends Neurosci. 10, 211-216.
39. Lassmann, H., Zimprich, F., Vass, K. and Hickey, W.F. (1991) Microglia cells are a component of the perivascular glia limitans. J. Neurosci. Res. 28, 236-243.
40. Mackenzie, A., Suckling, A.J., Jagelman, S. and Wilson, A.M. (1978) Histopathological and enzyme histochemical changes in experimental Semliki Forest virus infection and their relevance to scrapie. J. Comp. Path. 88, 335-344.
41. Male, D. and Pryce, G. (1988). Kinetics of MHC gene expression and mRNA synthesis in brain endothelium. Immunology. 63, 37-42.
42. Massa, P., Dörries, R. and ter Meulen, V. (1986). Viral particles induce Ia expression on astrocytes. Nature 320, 543-546.
43. Merrill, J.E., Kono, D.H., Clayton, J., Ando, D.G., Hinton, D.R. and Hofman, F.M. (1992) Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89, 574-578.
44. Miller, S.D. and Gerety, S.J. (1990) Immunological aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin. Virol. 1, 263-272.
45. Mokhtarian, F., Shi, Y., Zhu, P-F. and Grob, D. (1994) Immune responses, and autoimmune outcome, during virus infection of the central nervous system. Cell. Immunol. 157, 195-210.
46. Morganti-Kossmann, M.C., Kossman, T. and Wahl, S.M. (1992) Cytokines and neuropathology. Trends. Pharmacol. Sci. 13, 286-291.
47. Moritani, M., Yoshimoto, K., Tashiro, F., Miyazaki, J., Ii, S., Kudo, E., Iwahana, H., Hayashi, Y., Sano, T and Itakura, M. (1994) Transgeneic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Inter. Immunol. 6(2), 1927-1936.
48. Mucke, L. and Oldstone, M.B.A. (1992) The expression of major histocompatability complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV). J. Neuroimmunol. 36(2-3), 193-198.
49. Nishimoto, N., Yoshizaki, K., Eiraku, N., Machigashira, K., Tagoh, H., Ogata, A., Kuritani, T., Osame, M. and Kishimoto, T. (1990) Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I associated myelopathy/tropical spastic paraparesis. J. Neurol. Sci. 97, 183-193.
50. Oldstone, M.B.A. (1989) Viral persistence. Cell. 56, 517-520.
51. Parsons, L.M. and Webb, H.E. (1989) Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus. Br. J. Exp. Path. 70, 247-255.
52. Pathak, S., Illavia, S.J. and Webb, H.E. (1983) The identification and role of cells involved in CNS demyelination in mice after Semliki Forest virus infection: An ultrastructural study. In: Immunology of Nervous System Infections, Progress in Brain Research, Vol 59. Elsevier Science Publication, pp. 237-254.
53. Paya, C.V., Leibson, P.J., Patick, A.K. and Rodriguez, M. (1990) Inhibition of Theiler's virus induced demylination in vivo by tumor necrosis factor α. Int. Immunol. 2, 909-913.
54. Peterson, J.C., Waterenbaugh, C. and Miller, S.D. (1992) IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immunization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology 75, 652-658.
55. Piddlesden, S.J., Lassmann, H., Zimprich, F., Morgan, B.P. and Linington, C. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143, 555-564.
56. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N.H. and Steinman, L. (1990) Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2, 539-544.
57. Ranges, G E., Figari, I.S., Espevik, T. and Palladino, M.A. (1987) Inhibition of cytotoxic T cell development by transforming growth factor-β and reversal by tumor necrosis factor-α. J. Exp. Med. 166, 991-998.
58. Racke, M.K., Dhib-Jalbut, S., Cannella, B., Albert, P.S., Raine, C.S. and McFarlin, D.E. (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β. J. Immunol. 146, 3012-3017.
59. Ramsay, A.J., Ruby, J. and Ramshaw, I.A. (1993) A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14, 155-157.
60. Renno, T., Lin, J.Y., Piccirillo, C., Antel, J. and Owens, T. (1994) Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49, 1-7.
61. Rodriguez, M., Pavelko, K.D., McKinney, C.W. and Leibowitz, J.L. (1994) Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153, 3811-3820.
62. Schluesener, H., Sobel, R., Linington, C. and Weiner, H. (1987) A monoclonal antibody against a myelin oligodendrocye glycoprotein induces relapses and demyelination in CNS autoimmune disease. J. Immunol. 139, 4016-4021.
63. Selmaj, K.W. and Raine, C.S. (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
64. Selmaj, K.W., Raine, C.S. and Cross, A.M. 1991a. Identification of lymphotoxin and tumour necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
65. Selmaj, K.W., Raine, C.S. and Cross, A.M. (1991b) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30, 694-700.
66. Sierra, A. and Rubio, N. (1993) Theiler's murine encephalomyelitis virus induces tumour necrosis factor-alpha in murine astrocyte cultures. Immunology 78, 399-404.
67. + cells and suppression of antibody formation. J. Immunol. 147, 3581-3586.
68. + T cells prevents lesions of demyelination in Semliki Forest virus infection. J. Virol. 67, 7629-7633.
69. Tanaka, M. and McCarron, R.M. (1990) The inhibitory effect of tumor necrosis factor and interleukin-1 on Ia induction by interferon-gamma on endothelial cells from murine central nervous system microvessels. J. Neuroimmunol. 27(2-3), 209-215.
70. Traugott, U. (1987) Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J. Neuroimmunol. 16, 283-302.
71. Wesselingh, S.L., Levine, B., Fox, R.J., Choi, S. and Griffin, D.E. (1994) Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152, 1289-1297.
72. Wong, G.H.W., Bartlett, P.F., Dark-Lewis, I., Battye, F. and Schrader, J.W. (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310, 688-691.
73. Wong, G.H.W. and Goeddel, D.V. (1986). Tumor necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature 323, 819-822.
74. Woodruff, M.N. and Cuzner, M.L. (1993) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5, 583-588.